The loss of patent protection on Amarin’s sole commercial product Vascepa in 2020 has led to a roller coaster ride for the Dublin-based company over the past few years. But, now, the dr-gmaker is getting a fresh shot to challenge Hikma... — read more
Huge layoffs at Amarin
We knew this was coming, so I hope everybody already has a plan for how to proceed. I know I do. I have to admit that the Kalb news surprised me. I didn't think we'd see any casualties from the ELT but apparently, I was wrong. It's good to see that... — read more
Fda approval?
Is there any news? We are down to the wire here.
amrn stock message board
is there such a thing? i have seen yahoo finance board for the ticker, messages are of very little use
Any news?
Any news?
Layoffs happening right now..
Layoffs happening right now... This message was posted back in Dec of 2012: Amarin's looking for 300 intial reps to be engaged before Q1 of 2013. Additional 1000 will be added by the end of the year (technically after Anchor approval). Lipitor... — read more